- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 40.6M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 40.49M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 40.14M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$6.41M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.91M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $441.88M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $464.44M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $8.57M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $20.36M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $34.67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $350.98M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $353.62M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $346.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $345.69M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $456.11M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $486.03M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $807.09M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $839.65M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.23 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.27 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.23 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.27 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.02M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.01M |
| Net Income | Q1 2026 · Mar 31, 2026 | $6.16M |
| Net Income | Q1 2026 · Mar 31, 2025 | $12.69M |